Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Noninvasive ventilation in severe stable COPD: is it effective, and if so, in what way?

M. L. Duiverman, F. M. Struik, P. J. Wijkstra
European Respiratory Journal 2008 31: 1136-1137; DOI: 10.1183/09031936.00168207
M. L. Duiverman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. M. Struik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. J. Wijkstra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editors:

We read with interest the systematic review of Kolodziej et al. 1 about noninvasive positive-pressure ventilation (NPPV) in severe stable chronic obstructive pulmonary disease (COPD). First of all, we would like to compliment the authors on their excellent review. It is extremely important that good-quality reviews are published in the field of NPPV in severe stable COPD. The development of new therapeutic options in these patients is increasingly being recognised as urgently needed 2.

However, we would like to comment on the conclusions Kolodziej et al. 1 draw in their review. They conclude that bilevel NPPV used in a select proportion of patients with severe stable COPD can improve gas exchange, exercise tolerance, dyspnoea, work of breathing, frequency of hospitalisation, health-related quality of life and functional status. Following this, they suggest an adjunctive role for the …

View Full Text
PreviousNext
Back to top
View this article with LENS
Vol 31 Issue 5 Table of Contents
European Respiratory Journal: 31 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Noninvasive ventilation in severe stable COPD: is it effective, and if so, in what way?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Noninvasive ventilation in severe stable COPD: is it effective, and if so, in what way?
M. L. Duiverman, F. M. Struik, P. J. Wijkstra
European Respiratory Journal May 2008, 31 (5) 1136-1137; DOI: 10.1183/09031936.00168207

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Noninvasive ventilation in severe stable COPD: is it effective, and if so, in what way?
M. L. Duiverman, F. M. Struik, P. J. Wijkstra
European Respiratory Journal May 2008, 31 (5) 1136-1137; DOI: 10.1183/09031936.00168207
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • References
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Ethical obligations for supporting healthcare workers during the COVID-19 pandemic
  • Is high-dose glucocorticoid beneficial in COVID-19? Response to Correspondence
  • BALF lymphocytosis in chronic hypersensitivity pneumonitis
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society